0001832334-20-000001.txt : 20201116 0001832334-20-000001.hdr.sgml : 20201116 20201116141033 ACCESSION NUMBER: 0001832334-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201116 DATE AS OF CHANGE: 20201116 EFFECTIVENESS DATE: 20201116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrano Therapeutics, Inc. CENTRAL INDEX KEY: 0001832334 IRS NUMBER: 461891229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380646 FILM NUMBER: 201315517 BUSINESS ADDRESS: STREET 1: 5125 MACARTHUR BLVD. NW, #20 CITY: WASHINGTON STATE: DC ZIP: 20016 BUSINESS PHONE: 1 (925) 822-6461 MAIL ADDRESS: STREET 1: 5125 MACARTHUR BLVD. NW, #20 CITY: WASHINGTON STATE: DC ZIP: 20016 D 1 primary_doc.xml X0708 D LIVE 0001832334 Cyrano Therapeutics, Inc. 5125 MACARTHUR BLVD. NW, #20 WASHINGTON DC DISTRICT OF COLUMBIA 20016 1 (925) 822-6461 DELAWARE None None Corporation true Richard Geoffrion 5125 MacArthur Blvd. NW, #20 Washington DC DISTRICT OF COLUMBIA 20016 Executive Officer Director Robert Henkin 5125 MacArthur Blvd. NW, #20 Washington DC DISTRICT OF COLUMBIA 20016 Director Takahide Koda 1601 Fifth Avenue, Suite 1100 Seattle WA WASHINGTON 98101-3603 Director Gerry Brunk 141 Adelaide Street West, Suite 770 Toronto A6 ONTARIO, CANADA M5H 3L5 Director Other Health Care Decline to Disclose 06b false 2020-11-04 true true false 0 12804250 4082754 8721496 false 11 0 0 0 false Cyrano Therapeutics, Inc. Richard Geoffrion Richard Geoffrion President 2020-11-05